Magdalena Krol, n/a

Director of the Center, CEO
Center of Cellular Immunotherapies, Warsaw University of Life Sciences and Cellis AG (Switzerland), Switzerland

Poster(s):

• W162 - Macrophage-Drug Conjugate (MDC): A Promising Paradigm for Cell-Based Immunotherapy for Solid Tumors
  Wednesday, June 19, 2024

  7:30 AM – 7:30 PM PT